Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DataMeds AI, Inc. - Common Stock
(NQ:
MEDS
)
3.950
+0.780 (+24.61%)
Delayed Quote
Updated: 10:52 AM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DataMeds AI, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
Today 6:00 EDT
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI and Tollo Health Announce Launch of ‘Health Lives Here’ Mobile Application
September 28, 2026
DataMeds AI, Inc. (NASDAQ:MEDS), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform...
Via
B2i Digital
Topics
Artificial Intelligence
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
September 28, 2026
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
August 12, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
September 25, 2026
DataMeds AI, Inc. (NASDAQ:MEDS) announced that its Interim Co-CEO Gerald Commissiong will present “What Patients Really Want” at this year’s National Telehealth and Virtual Care Summit in Las Vegas on...
Via
B2i Digital
Topics
Artificial Intelligence
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
September 25, 2026
Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMEDS AI Unveils New Corporate Website
September 21, 2026
DataMEDS AI, Inc. (NASDAQ:MEDS) (the “Company” or “DataMEDS”), a Health IT company vertically integrating health data acquisition and transfer, today announced that it launched its new corporate...
Via
B2i Digital
Topics
Artificial Intelligence
Retirement
DataMEDS AI Unveils New Corporate Website
September 21, 2026
Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
September 18, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
Small-Cap Stocks VEEA, ANY, MEDS, MYSZ Watch Now
September 15, 2026
Via
AB Newswire
Topics
Artificial Intelligence
DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
September 15, 2026
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
September 15, 2026
All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scaling GPU-as-a-Service business
From
Axe Compute Inc
Via
GlobeNewswire
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
September 08, 2026
Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
August 27, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
August 27, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
August 17, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record
August 14, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
August 10, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
August 06, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
August 05, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
July 31, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands DataMEDS Licensing Agreement Into Commercial Healthcare
July 29, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
July 29, 2026
From
Datavault AI Inc.
Via
Business Wire
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
July 29, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
July 27, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
July 22, 2026
From
DataMEDS AI, Inc.
Via
ACCESS Newswire
TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.
September 20, 2024
Via
Investor Brand Network
BioMedNewsBreaks — TRxADE Health Inc.’s (NASDAQ: MEDS) Subsidiary Expands Capabilities with Changes to Executive Leadership Team
August 05, 2024
Via
Investor Brand Network
BioMedNewsBreaks — TRxAde Health Inc. (NASDAQ: MEDS), Scienture Inc. Announce All-Stock Business Combination Resulting in Combined Company
July 26, 2024
Via
Investor Brand Network
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 22, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit